/ Sep 30, 2026
/ Sep 30, 2026

INEC deadline deepens post-primary tensions as parties rush candidate submissions for 2027 polls

Published on

By

Political parties are under mounting pressure to resolve post-primary disputes and complete candidate nominations after the Independent National Electoral Commission (INEC) fixed July 11, 2026, as the deadline for submitting candidates’ particulars for the 2027 general elections.

 

According to The PUNCH, INEC will issue access codes to political parties on June 26, enabling them to begin uploading candidates’ details to the commission’s nomination portal from June 27.

INEC Chairman, Joash Amupitan, said designated national officers would be responsible for submitting nominees’ biodata and other required information through the automated portal, warning that the system would close automatically once the deadline expires.

The development comes amid lingering disputes from party primaries, appeals by aggrieved aspirants, leadership battles and legal challenges to parts of INEC’s election timetable.

Amupitan expressed concern that unresolved internal party conflicts and court cases could complicate preparations for the 2027 elections, urging political actors to resolve disputes quickly.

The commission also revealed it has appealed two recent Federal High Court judgments involving its election timetable. One case was filed by the Youth Party, while another was brought by the Social Democratic Party. INEC argues that the electoral timetable is an interconnected framework and that removing specific timelines could disrupt election planning.

Several political parties said they are preparing to meet the deadline.

The African Democratic Congress said it is currently addressing appeals arising from its primaries before forwarding candidates’ names to INEC.

The Young Progressives Party, All Progressives Grand Alliance, Social Democratic Party, Labour Party and Nigerian Democratic Congress all indicated they are compiling or finalising candidate lists ahead of the deadline.

While the NDC has already unveiled a presidential ticket featuring Peter Obi and Musa Kwankwaso, both the Labour Party and SDP said consultations are ongoing over their vice-presidential candidates.

The Labour Party’s presidential candidate, Chibuzo Okereke, is yet to announce a running mate, while SDP candidate Adewole Adebayo is consulting party stakeholders before making a decision.

Meanwhile, former Vice President Atiku Abubakar has intensified consultations over his own vice-presidential choice. Sources within the ADC suggested former Rivers State governor Rotimi Amaechi is a leading contender, although media entrepreneur Dele Momodu has also been mentioned by some party loyalists.

Atiku’s spokesman, Phrank Shaibu, described recent meetings between Atiku and Amaechi as part of wider consultations aimed at building a credible opposition platform ahead of the 2027 election.

INEC maintained that despite ongoing litigation, preparations for the polls remain on schedule and pledged to conduct the elections in line with constitutional and legal requirements.

You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Must Read

Japanese surgeons perform the world’s first heart muscle stem cell surgery using iPS-derived cells

Japan performs world’s first heart muscle stem cell surgery

A hospital in Japan has performed the world’s first surgery using commercially available sheets of heart muscle cells derived from induced pluripotent stem cells, marking a significant step in regenerative heart treatment.   The procedure was carried out on Tuesday at Osaka Keisatsu Hospital on a woman in her 50s. The hour-long operation involved transplanting sheets of heart muscle cells into her heart. The treatment received conditional government approval in Japan in March, allowing its first clinical use. “Our hope is that this will improve the patient’s quality of life,” surgeon Yoshiki Sawa, head of Osaka Keisatsu Hospital, told reporters after the operation. The regenerative therapy was previously tested on eight patients with ischaemic heart disease, a condition in which narrowed heart arteries reduce blood flow to the heart. According to Japanese media reports, all eight patients experienced an easing of symptoms, while four recorded improvements in heart function. Sawa developed the technology in collaboration with Japanese scientist Shinya Yamanaka, who won the 2012 Nobel Prize in Physiology or Medicine for his research into induced pluripotent stem cells, commonly known as iPS cells. iPS cells are created by reprogramming mature specialised cells into a more flexible, juvenile-like state, allowing them to develop into different types of cells. The therapy is primarily intended for heart patients who have exhausted other treatment options. It is expected to help improve heart muscle function, heart failure symptoms, cardiac performance and exercise tolerance. Sawa’s team plans to carry out similar procedures on 75 patients by 2033 as part of efforts to establish the treatment’s effectiveness and safety. The treatment could receive full authorisation if its benefits and safety are demonstrated during the seven-year evaluation period, according to Japanese media reports. Japan also granted conditional approval in March for an iPS cell-based treatment for Parkinson’s disease following a successful clinical trial.
Read more

Editor's Pick

Trending News

Newsletter

Enter your email address and receive notifications of news by email.

You have been successfully Subscribed! Ops! Something went wrong, please try again.

© 2026 GongNews. All Rights Reserved.